Ballentine Partners, LLC - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 175 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ballentine Partners, LLC ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$336,000
-19.8%
20,0000.0%0.02%
-21.7%
Q2 2018$419,000
-13.3%
20,000
-33.3%
0.02%
-14.8%
Q1 2018$483,000
-15.1%
30,0000.0%0.03%
-12.9%
Q4 2017$569,000
+34.8%
30,0000.0%0.03%
+34.8%
Q3 2017$422,000
+110.0%
30,000
+20.0%
0.02%
+53.3%
Q2 2017$201,00025,0000.02%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,177,115$1,518,0001.37%
CM Management, LLC 600,000$774,0000.65%
ARMISTICE CAPITAL, LLC 17,100,000$22,059,0000.43%
Sargent Investment Group, LLC 414,600$535,0000.14%
Ergoteles LLC 299,005$386,0000.02%
Sonora Investment Management Group, LLC 82,000$106,0000.01%
MCDONALD PARTNERS LLC 42,570$55,0000.01%
CAXTON ASSOCIATES LP 107,135$138,0000.01%
Crestline Management, LP 66,209$85,0000.01%
D. E. Shaw & Co., Inc. 7,845,726$10,121,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders